OPKO Health, Inc. (NASDAQ:OPK – Get Rating) – HC Wainwright increased their Q1 2023 EPS estimates for shares of OPKO Health in a research note issued on Thursday, March 9th. HC Wainwright analyst Y. Chen now expects that the biotechnology company will earn ($0.02) per share for the quarter, up from their prior estimate of ($0.07). HC Wainwright has a “Buy” rating and a $3.00 price objective on the stock. The consensus estimate for OPKO Health’s current full-year earnings is ($0.31) per share. HC Wainwright also issued estimates for OPKO Health’s FY2023 earnings at ($0.22) EPS.
OPKO Health Stock Up 2.5 %
Shares of NASDAQ OPK opened at $1.24 on Monday. The company has a 50 day simple moving average of $1.27 and a 200-day simple moving average of $1.57. The company has a market capitalization of $958.09 million, a P/E ratio of -2.82 and a beta of 1.64. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.85 and a quick ratio of 1.50. OPKO Health has a 1 year low of $1.00 and a 1 year high of $3.78.
Institutional Trading of OPKO Health
A number of large investors have recently made changes to their positions in the company. Humankind Investments LLC purchased a new position in OPKO Health in the 3rd quarter valued at approximately $25,000. Zacks Investment Management acquired a new stake in OPKO Health during the 3rd quarter valued at $25,000. Sax Wealth Advisors LLC acquired a new stake in OPKO Health during the 4th quarter valued at $25,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in OPKO Health by 67.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,083 shares of the biotechnology company’s stock valued at $29,000 after buying an additional 9,308 shares during the last quarter. Finally, Gladius Capital Management LP acquired a new stake in OPKO Health during the 4th quarter valued at $31,000. 23.49% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at OPKO Health
In other news, major shareholder Opko Health, Inc. purchased 14,285,714 shares of the business’s stock in a transaction dated Thursday, January 26th. The stock was acquired at an average price of $0.35 per share, for a total transaction of $4,999,999.90. Following the acquisition, the insider now directly owns 94,285,714 shares of the company’s stock, valued at $32,999,999.90. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other OPKO Health news, major shareholder Opko Health, Inc. purchased 14,285,714 shares of the firm’s stock in a transaction on Thursday, January 26th. The stock was bought at an average price of $0.35 per share, with a total value of $4,999,999.90. Following the transaction, the insider now directly owns 94,285,714 shares of the company’s stock, valued at approximately $32,999,999.90. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Phillip Md Et Al Frost purchased 1,000,000 shares of the firm’s stock in a transaction on Wednesday, March 8th. The stock was acquired at an average cost of $1.18 per share, with a total value of $1,180,000.00. Following the transaction, the chief executive officer now directly owns 199,831,694 shares in the company, valued at $235,801,398.92. The disclosure for this purchase can be found here. Insiders own 40.97% of the company’s stock.
OPKO Health Company Profile
OPKO Health, Inc is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations.
- Get a free copy of the StockNews.com research report on OPKO Health (OPK)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Receive News & Ratings for OPKO Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPKO Health and related companies with MarketBeat.com's FREE daily email newsletter.